Susquehanna International Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,893
| Closed | -$33.5K | – | 6808 |
|
|
2024
Q1 | $33.5K | Buy |
+3,893
| New | +$33.5K | ﹤0.01% | 5228 |
|
|
2023
Q4 | – | Sell |
-792
| Closed | -$2.82K | – | 6816 |
|
|
2023
Q3 | $2.82K | Buy |
+792
| New | +$2.82K | ﹤0.01% | 5413 |
|
|
2023
Q2 | – | Sell |
-2,094
| Closed | -$79.1K | – | 6678 |
|
|
2023
Q1 | $79.1K | Buy |
+2,094
| New | +$79.1K | ﹤0.01% | 5321 |
|
|
2022
Q4 | – | Sell |
-646
| Closed | -$22K | – | 6985 |
|
|
2022
Q3 | $22K | Buy |
+646
| New | +$22K | ﹤0.01% | 5700 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6876 |
|
|
2022
Q1 | – | Sell |
-986
| Closed | -$55K | – | 6710 |
|
|
2021
Q4 | $55K | Buy |
+986
| New | +$55K | ﹤0.01% | 5448 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6252 |
|
|
2021
Q2 | – | Sell |
-629
| Closed | -$104K | – | 6062 |
|
|
2021
Q1 | $104K | Buy |
+629
| New | +$104K | ﹤0.01% | 4976 |
|
|
2019
Q3 | – | Sell |
-192
| Closed | -$26K | – | 5138 |
|
|
2019
Q2 | $26K | Buy |
+192
| New | +$26K | ﹤0.01% | 4340 |
|
|
2019
Q1 | – | Sell |
-217
| Closed | -$27K | – | 4784 |
|
|
2018
Q4 | $27K | Buy |
217
+162
| +295% | +$20.2K | ﹤0.01% | 3417 |
|
|
2018
Q3 | $22K | Sell |
55
-44
| -44% | -$17.6K | ﹤0.01% | 3174 |
|
|
2018
Q2 | $53K | Sell |
99
-18
| -15% | -$9.64K | ﹤0.01% | 3406 |
|
|
2018
Q1 | $54K | Buy |
+117
| New | +$54K | ﹤0.01% | 3102 |
|
|
2015
Q2 | – | Sell |
-62
| Closed | -$173K | – | 4803 |
|
|
2015
Q1 | $173K | Buy |
+62
| New | +$173K | ﹤0.01% | 3779 |
|